Chris Spahr joined Amgen after graduation from UCSB in 1994 (B.S., Pharmacology) and is currently in the Discovery Attribute Sciences group. His primary focus is protein analytics using mass spectrometry and other related techniques. Other expertise includes PTM analysis (especially N- and O-linked glycosylation), de novo sequencing, and nano-LC-MS/MS. He has published over 35 papers in peer-reviewed journals.